| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |